Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study

Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study

Abstract Background Calcitonin gene-related peptide (CGRP) has recently been implicated in the pathogenesis of post-traumatic headache (PTH), which raises the prospect for therapeutic use of monoclonal antibodies targeting CGRP or its receptor. Therefore, we decided to assess the efficacy, tolerabil...

Full description

Bibliographic Details
Main Authors: Håkan Ashina, Afrim Iljazi, Haidar Muhsen Al-Khazali, Anna Kristina Eigenbrodt, Eigil Lindekilde Larsen, Amalie Middelboe Andersen, Kevin John Hansen, Karoline Bendix Bräuner, Thomas Mørch-Jessen, Basit Chaudhry, Sonja Antic, Casper Emil Christensen, Messoud Ashina, Faisal Mohammad Amin, Henrik Winther Schytz
Format: Article
Language:English
Published: BMC 2020-06-01
Series:The Journal of Headache and Pain
Subjects:
Concussion
Secondary headache
Head trauma
Head injury
Clinical management
Online Access:http://link.springer.com/article/10.1186/s10194-020-01136-z

Internet

http://link.springer.com/article/10.1186/s10194-020-01136-z

Similar Items